Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance
Authors:
- 1 January 2020
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 45 (2) , 449-456
Abstract
Purpose To evaluate pancreatic T1 mapping and extracellular volume (ECV) fraction’s feasibility to assess impaired glucose tolerance (IGT) patients. Methods A total of 45 consecutive patients with known or suspected pancreatic disease underwent contrast-enhanced magnetic resonance (MR) imaging, including T1 mapping, using saturation recovery sequence. Patients were classified into three groups based on the American Diabetes Association criteria: no-diabetes subjects, HbA1c < 5.7%; pre-diabetes, 5.7% ≤ HbA1c < 6.5%; and type 2 diabetes mellitus (T2DM), HbA1c ≥ 6.5%. Pre-contrast pancreatic T1 value and ECV of the pancreas were computed, and then pre-contrast pancreatic T1 value, ECV and HbA1c values were compared. The present prospective study was approved by our institutional review board. Written informed consent was obtained from all patients. Results A positive correlation between HbA1c values and both pre-contrast pancreatic T1 value and ECV (r = 0.79, P < 0.001 and r = 0.60, P < 0.001, respectively) were observed. The pre-contrast pancreatic T1 value and ECV were significantly higher in T2DM vs. no-diabetes subjects and pre-diabetes (P < 0.001). No significant difference between two qualitative values (P = 0.14) was found, however, the sensitivity, specificity, and area under the receiver-operating-characteristic curve differentiating no-diabetes subjects and pre-diabetes from T2DM were superior in ECV (100%, 93.5%, and 0.990) vs. pre-contrast pancreatic T1 values (84.6%, 96.8%, and 0.906). Conclusions The ECV of the pancreas could serve as a potential imaging biomarker for the assessment of pancreatic fibrosis leading to IGT.Keywords
This publication has 22 references indexed in Scilit:
- State of the Art: Clinical Applications of Cardiac T1 MappingRadiology, 2016
- Inverse association of HbA1c with faecal elastase 1 in people without diabetesPancreatology, 2015
- Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditisEuropean Heart Journal - Cardiovascular Imaging, 2015
- Findings in pancreatic MRI associated with pancreatic fibrosis and HbA1c valuesJournal of Magnetic Resonance Imaging, 2015
- Arrhythmia insensitive rapid cardiac T1 mapping pulse sequenceMagnetic Resonance in Medicine, 2012
- Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial FibrosisCirculation, 2010
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.Gut, 1996
- Pancreatic signal intensity on Tl‐ weighted fat saturation MR images: Clinical correlationJournal of Magnetic Resonance Imaging, 1995
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983